Clinical Course of Individuals at Clinical High Risk for Psychosis: Transition or Remission
Open Access
- 31 October 2025
- journal article
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 28 (2) , 49-54
Abstract
Patients with psychoses often show various symptoms and signs before their onset of illnesses including developmental delay during childhood and adolescence, cognitive impairments such as impaired attention, mood symptoms such as depressed mood or mood fluctuation, anxiety symptoms, sleep problems, and functional impairments such as decline in academic or social functions. This period can also show psychosis-related symptoms such as attenuated forms of psychotic symptoms or full psychotic symptoms with limited duration falling short of diagnostic criteria of psychoses. When an individual is prospectively thought to be in this “prodromal” state of psychoses, the individual is regarded to be at clinical high risk for psychosis (CHR). Naturally, some of the individuals at CHR experience a psychotic transition during their clinical course, but the others show much diverse clinical course including improvement of symptoms, remission of symptoms, emergence or persistence of non-psychotic co-morbid illnesses, and various alterations of functional level. It is reported that the majority of individuals at CHR do not experience psychotic conversion but show diverse clinical courses otherwise. Although the state of CHR has numerous aspects to investigate, this review will focus on various clinical courses of individuals at CHR, including psychotic transition and remission.Keywords
This publication has 21 references indexed in Scilit:
- Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for PsychosisJAMA Network Open, 2025
- Clinical trajectories in the ultra-high risk for psychosis populationSchizophrenia Research, 2018
- Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High RiskJAMA Psychiatry, 2016
- Current status specifiers for patients at clinical high risk for psychosisSchizophrenia Research, 2014
- Attenuated psychosis syndrome in DSM-5Schizophrenia Research, 2013
- Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for PsychosisJAMA Psychiatry, 2013
- Early intervention in psychosis: Insights from KoreaAsian Journal of Psychiatry, 2012
- Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold SymptomsArchives of General Psychiatry, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceNew England Journal of Medicine, 2001